Class IIITerminatedD-0240-2017
Drug recall · January 4, 2017
Virt-Select Prenatal/Postnatal Softgels recall
Why: cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Virt-Select Prenatal/Postnatal Softgels, Prescription Multivitamin/Mineral Dietary Supplement with Fish-Based DHA , packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-249-30
- Lots / codes
Lots #: 21511153 Exp. date 10/30/2017
- Quantity
- 9,795 bottles
- Company
- Virtus Pharmaceuticals Opco II L, Nashville, TN
- Distribution
- Nationwide
- Initiated
- December 12, 2016 · Voluntary: Firm initiated
- Classified
- December 28, 2016
- Reported
- January 4, 2017
- Ended
- August 21, 2018
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IIITerminatedJan 4, 2017Virt-Advance Prenatal/Postnatal SoftgelsVirtus Pharmaceuticals Opco II L · D-0238-2017Class IIITerminatedJan 4, 2017Extra-Virt Plus DHA Prenatal/Postnatal SoftgelVirtus Pharmaceuticals Opco II L · D-0239-2017Class IIITerminatedJan 4, 2017VirtPrex Prenatal/Postnatal TabletsVirtus Pharmaceuticals Opco II L · D-0241-2017
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.